Services
Growth Innovation Operations
Cases
Insights
AGP Insights Eco Insiders Podcast
About
Contact
EN
中文

Personal Information

Upload Avatar (500 x 500)
Bing Chen
chenbing2004@126.com
Chinese, English
Jiangsu

Academic Information

Nanjing University
Medical School
  • 1995 - Nanjing Drum Tower Hospital - Clinical work in hematology
  • 2012 - Visiting Scholar at Memorial Sloan Kettering Cancer Center
  • 1995 - Present - Nanjing Drum Tower Hospital - Clinical work in hematology
  • 2012 - Visiting Scholar at Memorial Sloan Kettering Cancer Center
  • 2020 - Jiangsu Province Medical New Technology Introduction Award, First Prize
  • 2017 - Nanjing Science and Technology Progress Award, Third Prize
  • 2017 - Jiangsu Province Medical New Technology Introduction Award, Second Prize
  • 2017 - Jiangsu Oncology Medical Science and Technology Award, Second Prize
  • 2013 - Jiangsu Province Medical New Technology Introduction Award, First Prize
  • 2012 - Jiangsu Province Science and Technology Progress Award, Third Prize
  • 2011 - Nanjing Science and Technology Progress Award, Third Prize

Research

Basic and clinical research of multiple myeloma
Biological immunotherapy research of malignant hematological diseases
  • Identification of three immune molecular subtypes associated with immune profiles, immune checkpoints, and clinical outcome in multiple myeloma, Bing Chen, 2021
  • Bortezomib activation of mTORC1C1 pathway mediated by NOX2-drived reactive oxygen species results in apoptosis in primary dorsal root ganglion neurons, Bing Chen, 2021
  • Nomogram for Predicting the Overall Survival of Adult Patients With Primary Gastrointestinal Diffuse Large B Cell Lymphoma: A SEERBased Study, Bing Chen, 2020
  • Abnormal PTBP1 Expression Sustains the Disease Progression of Multiple Myeloma, Bing Chen, 2020
  • MiR-181a enhances drug sensitivity of mixed lineage leukemia-rearranged acute myeloid leukemia by increasing poly(ADP-ribose) polymerase1 acetylation, Bing Chen, 2020
  • Daunorubicin-Loaded CdTe QDs Conjugated with Anti-CD123 mAbs: A Novel Delivery System for Myelodysplastic Syndromes Treatment, Bing Chen, 2020
  • Comparison of Antifungal Prophylaxis Drugs in Patients With Hematological Disease or Undergoing Hematopoietic Stem Cell Transplantation A Systematic Review and Network Meta-analysis, Bing Chen, 2020
  • BAG3 regulates multiple myeloma cell proliferation through FOXM1/Rb/E2F axis, Bing Chen, 2020
  • Vincristine-loaded platelets coated with anti-CD41 mAbs: a new macrophage targeting proposal for the treatment of immune thrombocytopenia, Bing Chen, 2019
  • Higher single dose of bortezomib plus thalidomide and dexamethasone is a promising therapy for newly diagnosed multiple myeloma, Bing Chen, 2019
  • TREM1/Dap12-based CAR-T cells show potent antitumor activity, Bing Chen, 2019
  • Prognostic Value of 1q21 Gain in Multiple Myeloma, Bing Chen, 2019
  • Development of follicular lymphoma after treatment of diffuse large B-cell lymphoma: two case reports with review of literature, Bing Chen, 2018
  • Pre-treatment red blood cell distribution width provides prognostic information in multiple myeloma, Bing Chen, 2018
  • Doxorubicin-Loaded PEG-CdTe Quantum Dots as a Smart Drug Delivery System for Extramedullary Multiple Myeloma Treatment, Bing Chen, 2018
  • Acute lymphoblastic leukemia in a patient with IgG4-related disease, Bing Chen, 2018
  • Anti-CD22-conjugated CdTe QDs co-loaded with doxorubicin and gambogic acid: a novel platform for lymphoma treatment, Bing Chen, 2017
  • Characteristics and mutation analysis of Ph-positive leukemia patients with T315I mutation receiving tyrosine kinase inhibitors, Bing Chen, 2017
  • The association between expression of hypoxia inducible factor1α and multi-drug resistance of acute myeloid leukemia, Bing Chen, 2017
  • The polymorphism of JAK2 rs56118985 may be a predictive marker of the treatment responses of acute myeloid leukemia patients, Bing Chen, 2017
  • Expression of MAGEC1/CT7 provides prognostic information in multiple myeloma, Bing Chen, 2017
Keywords
Multiple Myeloma Clinical Research Basic Research Hematology Immunotherapy Malignant Diseases Biological Therapy Stem Cell Transplantation Leukemia Targeted Therapy
Related Professors
Yongchang Wei - Wuhan University
Area of Focus
Gastric Cancer | Intestinal Cancer | Radiotherapy | Chemotherapy | Immunotherapy | Treatment Advancements | Malignant Tumors | Basic Research | Comprehensive Treatment | Oncology
Xianlong Zhou - Wuhan University
Area of Focus
Cardiovascular | Respiratory | Critical Care | Treatment | Clinical Research | Basic Research | Diaphragm Dysfunction | Cardiopulmonary Resuscitation | Cerebral Resuscitation | Emergency Medicine
Jing Chen - Wuhan University
Area of Focus
Vascular Repair | Myocardial Repair | Interventional Cardiology | Coronary Heart Disease | Vascular Injury | Heart Failure | Stent Implantation | Coronary Angiography | Clinical Research | Basic Research
View All
© 2015-2024 Asia Growth Partners Limited | Privacy Policy

Contact us

Let's talk!
* Required
* Required
* Required
* Invalid email address
By submitting this form, you agree that IoT ONE may contact you with insights and marketing messaging.
No thanks, I don't want to receive any marketing emails from IoT ONE.
Submit

Thank you for your message!
We will contact you soon.